MDXG Mimedx Group Inc

Price (delayed)

$4.77

Market cap

$695.28M

P/E Ratio

119.25

Dividend/share

N/A

EPS

$0.04

Enterprise value

$576.64M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 47

MiMedx is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. ...

Highlights
The quick ratio has increased by 23% YoY
The debt has contracted by 7% YoY and by 2.2% from the previous quarter
Mimedx Group's EPS has shrunk by 82% YoY and by 81% QoQ
MDXG's net income has shrunk by 81% YoY and by 80% QoQ

Key stats

What are the main financial stats of MDXG

MDXG stock price

How has the Mimedx Group stock price performed over time
Intraday
-3.25%
1 week
0.85%
1 month
10.16%
1 year
-32.91%
YTD
-29.54%
QTD
23.9%

Financial performance

How have Mimedx Group's revenue and profit performed over time
Revenue
$355.17M
Gross profit
$280.05M
Operating income
$8.73M
Net income
$6.24M
Gross margin
78.8%
Net margin
1.8%
MDXG's net income has shrunk by 81% YoY and by 80% QoQ
The operating income has shrunk by 80% YoY and by 78% QoQ
The net margin has plunged by 80% YoY and by 77% from the previous quarter
The operating margin has plunged by 79% YoY and by 75% from the previous quarter

Price vs fundamentals

How does MDXG's price correlate with its fundamentals

Growth

What is Mimedx Group's growth rate over time

Valuation

What is Mimedx Group stock price valuation
P/E
119.25
P/B
3.29
P/S
1.98
EV/EBIT
58.58
EV/EBITDA
25.28
EV/Sales
1.62
Mimedx Group's EPS has shrunk by 82% YoY and by 81% QoQ
Mimedx Group's equity has decreased by 11% QoQ
The P/B is 3% higher than the last 4 quarters average of 3.3
The P/S is 15% lower than the 5-year quarterly average of 2.4 but 2.5% higher than the last 4 quarters average of 2.0
MDXG's revenue is down by 9% from the previous quarter and by 2.4% YoY

Efficiency

How efficient is Mimedx Group business performance
Mimedx Group's return on equity has shrunk by 84% YoY and by 80% QoQ
MDXG's ROA has shrunk by 83% YoY and by 79% QoQ
Mimedx Group's return on sales has shrunk by 77% YoY and by 73% QoQ
MDXG's return on invested capital has dropped by 75% year-on-year and by 75% since the previous quarter

Dividends

What is MDXG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MDXG.

Financial health

How did Mimedx Group financials performed over time
The quick ratio has increased by 23% YoY
The current ratio has increased by 21% year-on-year
The debt is 92% less than the equity
MDXG's debt to equity is up by 14% since the previous quarter but it is down by 11% year-on-year
Mimedx Group's equity has decreased by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.